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Characteristics of Chinese patients with Wegener’s granulo-
matosis with anti-myeloperoxidase autoantibodies.
Background. Cytoplasmic antineutrophil cytoplasmic
autoantibodies (cANCA)/proteinase-3(PR3)-ANCA was
considered the serologic diagnostic marker for Wegener’s
granulomatosis (WG). However, Chinese patients with
MPO-ANCA positive WG were frequently diagnosed. We
now analyze the characteristics of patients with MPO-ANCA
positive WG and investigate the difference between patients
with MPO-ANCA and PR3-ANCA.
Methods. Patients with WG were selected according to both
Chapel Hill Consensus Conference definition and American
College of Rheumatology (ACR) classification criteria in 500
Chinese patients with ANCA-associated systemic vasculitides.
The clinical manifestions were compared between patients with
MPO-ANCA and with PR3-ANCA.
Results. Eight-nine patients fulfilled the diagnostic criteria of
WG: 54/89(60.7%) were MPO-ANCA positive, 34/89(38.2%)
were PR3-ANCA positive. Patients with MPO-ANCA were
predominantly female compared with patients with PR3-
ANCA. Patients with MPO-ANCA also had multisystem in-
volvement. However, the prevalences of arthagia, skin rash,
ophthalmic and ear involvement were significantly lower in
patients with MPO-ANCA than those in patients with PR3-
ANCA (46.3% vs. 70.6%, P < 0.05; 20.4% vs. 44.1%, P < 0.05;
27.8% vs. 58.8%, P < 0.01; 40.7% vs. 67.6%, P < 0.05, respec-
tively). The prevalence of elevated initial serum creatinine was
significantly higher in patients with MPO-ANCA than that in
patients with PR3-ANCA (81.5% vs. 61.8%, v 2 = 4.20, P <
0.05).
Conclusion. Patients with MPO-ANCA positive WG were
not rare in Chinese.
Wegener’s granulomatosis (WG) is a systemic vas-
culitis characterized by necrotizing granulomatous in-
flammation of the upper and lower respiratory tract
and kidney. Antineutrophil cytoplasmic autoantibodies
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(ANCA) are useful diagnostic tools for WG, micro-
scopic polyangiitis (MPA), and Churg-Strauss syndrome
(CSS), which are categorized as ANCA-associated sys-
temic vasculitides. Two patterns of ANCA are distin-
guished by indirect immunofluorescence (IIF) technique,
the cytoplasmic staining pattern (cANCA) and the per-
inuclear staining pattern (pANCA). Most patients with a
cANCA pattern obtained by IIF have ANCA directed
against proteinase-3(PR3), as determined by antigen-
specific enzyme-linked immunosorbent assay (ELISA).
Patients with a pANCA mostly have ANCA directed
against one of a variety of antigens, such as myeloper-
oxidase (MPO). cANCA/PR3-ANCA was found in 70%
to 90% of patients with active WG and was often consid-
ered by some to be a seromarker for this disease [1–4].
In contrast, pANCA/MPO-ANCA was observed in only
5% to 10% of patients with WG, and was far less than
cANCA/PR3-ANCA [5–7].
In the past eight years, 500 patients with ANCA-
associated systemic vasculitides were diagnosed in
Institute of Nephrology, Peking University First Hospi-
tal. However, patients with pANCA/MPO-ANCA posi-
tive WG were frequently diagnosed. In 15 patients with
pathologic proven WG, 10 (66.7%) were pANCA/MPO-
ANCA positive. The current study retrospectively inves-
tigated the prevalence and antigen-specificity of ANCA
in sera from Chinese patients with WG, and a compari-




From the 500 patients with ANCA-associated systemic
vasculitides, diagnosed from 1997 to 2004 in the Institute
of Nephrology, Peking University First Hospital, patients
fulfilled both following criteria of WG were recruited in
this retrospective study: (1) Chapel Hill Consensus Con-
ference (CHCC) definition [8]: granulomatous inflam-
mation involving the respiratory tract, and necrotizing
vasculitis affecting small- to medium-sized vessels (e.g.,
capillaries, venules, arterioles, and arteries); necrotizing
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Table 1. Number of patients who met the 1990 ACR criteria of WG
MPO-ANCA(+) PR3-ANCA(+) MPO- and PR3-ANCA(+) Total
(N = 54) (N = 34) (N = 1) (N = 89)
Nasal or oral 25 21 0 46
inflammation (46.3%) (61.8%) (0.0%) (51.7%)
Abnormal chest radiograph 39 24 0 63
(nodules, cavities, or fixed infiltrates) (72.2%) (70.6%) (0.0%) (70.8%)
Abnormal urinary sediment 48 31 1 80
(red cell casts or greater than (88.9%) (91.2%) (100.0%) (89.9%)
five red blood cells per high-power field)
Granulomatous 10 5 0 15
inflammation on biopsy (18.5%) (14.7%) (0.0%) (16.9%)
glomerulonephritis is common. Patients were classified
as WG if they had systemic vasculitis and the presence
of granulomatous inflammation in a biopsy specimen or
the presence of clinical signs strongly suggestive of gran-
ulomatous disease, which comprised involvement of the
upper respiratory tract with nasal inflammation (puru-
lent/bloody nasal discharge), sinusitis, or otitis media or
lower respiratory tract manifestion with pulmonary nod-
ules, cavities, or fixed infiltrate; (2) American College
of Rheumatology (ACR) classification criteria of WG
(Table 1) [9].
Patients were classified as having MPA if they had sys-
temic vasculitis and the absence of granuloma formation
in a biopsy specimen and the absence of clinical signs
strongly suggestive of granulomatous disease.
Acute renal failure was defined by the presence of
progressively elevated serum creatinine or 15% declined
clearance rate of serum creatinine on the baseline within
days or weeks. Clinical and pathologic data were collected
and analyzed according to the organ involved.
IIF assay to detect ANCA
Standard IIF assay were performed accoding to
the manufacturer (EUROIMMUN, Lu¨beck, Germany).
Ethanol-fixed human polymorphonuclear leukocytes
(PMN) were used to detect ANCA and monkey liver
sections were used to exclude anti-nuclear antibodies
(ANA). cANCA and pANCA were distinguished accord-
ing to staining patterns by two experienced technicians.
Antigen-specific ELISAs
Two highly purified known ANCA antigens, PR3 and
MPO, purified as previously reported [10], were used as
solid phase ligands in ELISA. Antigens were diluted to 1
to 2 lg/mL with 0.05 mol/L bicarbonate buffer (pH 9.6)
and were coated onto the wells of one half of a Coatar
microtiter plate, the wells in the other half being coated
with coating buffer alone and acting as antigen-free wells.
The volumes of this step and subsequent steps were 100
lL, all incubations were carried out at 37◦ for 1 hour, and
plates were washed three times with phosphate-buffered
saline (PBS) containing 0.1% Tween-20 (PBST) between
stages. Test serum samples were diluted 1:50 with PBST
and coated in duplicate on both antigen-coated wells and
antigen-free wells; every plate contained positive, neg-
ative, and blank (PBST) controls. The binding was de-
tected with horseradish peroxidase conjugated goat an-
tihuman immunoglobulin (IgG; Gibco BRL, New York,
NY, USA) 1:5000 in PBST. The horseradish peroxidase
substrate o-phenylenediamine (OPD) was used at 0.4
mg/mL in 0.1 mol/L citrate phosphate buffer (pH 5.0).
The reaction was stopped by 2.0 mol/L H2SO4 and the re-
sults were recorded as the net A490 nm (average value of
antigen wells minus average value of antigen-free wells)
and expressed as percentage of the known positive con-
trols. Samples were considered positive if they exceeded
the mean +3 standard deviation (SD) from 100 normal
blood donors.
Disease-assessment instruments
Disease activity was measured by means of the Birm-
ingham Vasculitis Activity Score (BVAS) [11]. Scores can
range from 0 to 67, with higher scores indicating more
active disease. The extent of organ damage related to
vasculitis was assessed by means of the system score of
Vasculitis Damage Index (VDI) [12]. Scores for this in-
dex can range from 0 to 11, with higher scores indicating
more severe damage.
RESULTS
Demographic features and ANCA test
Eighty-nine patients fulfilled both diagnostic criteria
of Wegener’s granulomatosis from the 500 patients with
ANCA-associated systemic vasculitides. According to
the ACR criteria, 64/89, 24/89, and 1/89 patients had
two, three, and four items, respectively. The numbers of
patients who met each item of ACR criteria are listed
in Table 1. Fifty-four of 89 (60.7%) were pANCA posi-
tive, all could recognize MPO in antigen-specific ELISA.
Thirty-four of the 89 (38.2%) were cANCA positive and
all the sera recognized PR3. The other one (1/89, 1.1%)
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Table 2. Difference of patients with WG according to ANCA
MPO-ANCA(+) PR3-ANCA(+)
(N = 54) (N = 34)
Male/femalea 23/31 24/10
Age of onset of disease 52.8 ± 19.6 (3-80) 48.9 ± 16.0 (14-74)
Interval between onset 243.5, 60 212.7, 60
of the disease and diagnosis
(mean, median) days (range 7-1460) (range 8-1460)
Fever 38 (70.4%) 30 (88.2%)
Fatigue 42 (77.8%) 26 (76.5%)
Weight loss 30 (55.6%) 15 (44.1%)
Muscle pain 25 (46.3%) 15 (44.1%)
Arthragiaa 25 (46.3%) 24 (70.6%)
Skin rasha 11(20.4%) 15 (44.1%)
Renal 53 (98.1%) 32 (94.1%)
Elevation of initial Scra 44 (81.5%) 21 (61.8%)
Acute renal failure 34 (63.0%) 17 (50.0%)
Crescentic GN (N = 48) 23/33 (69.7%) 10/15 (66.7%)
Pulmonary 42 (77.8%) 27 (79.4%)
Hemoptysis 14 (25.9%) 14 (41.2%)
Pulmonary interstitial fibrosis 15 (27.8%) 6 (17.6%)
Ophthalmicb 15 (27.8%) 20 (58.8%)
Eara 22 (40.7%) 23 (67.6%)
Gastrointestinal 23 (42.6%) 14 (41.2%)
Nerve system 12 (22.2%) 10 (29.4%)
Anemia 42 (77.8%) 22 (64.7%)
Leukocytosis 27 (50.0%) 14 (41.2%)
Thrombocytosis 13 (24.1%) 9 (26.5%)
Elevated ESR 47 (87.0%) 29 (85.3%)
Elevated CRP 23 (42.6%) 21 (61.8%)
BVASa 22.2 ± 6.21 24.7 ± 6.87
VDI (system score) 2.61 ± 1.00 2.71 ± 0.94
aP < 0.05; bP < 0.01.
was positive for both pANCA and cANCA, and recog-
nized both PR3 and MPO.
Among the 89 patients, 15 were pathology proven WG.
Twelve were with renal biopsy, 8/12 were MPO-ANCA
positive, and the other four were PR3-ANCA positive;
two were with pulmonary biopsy and both were MPO-
ANCA positive; one was with nasal sinus biopsy and was
PR3-ANCA positive.
Among the 54 patients with MPO-ANCA, 23 were
male and 31 were female. The average age onset of the
disease was 52.8 (3–80) years old. The mean and median
interval between onset of the disease and diagnosis was
243.5 and 60 days, respectively.
Compared with 34 patients with PR3-ANCA, patients
with MPO-ANCA had significantly lower proportion of
male (42.6% vs. 70.6%, v 2 = 6.57, P < 0.05) (Table 2).
Nonspecific symptoms
Of the 54 cases with MPO-ANCA, 38 cases (38/54,
70.4%) had fever, 42 cases (42/54, 77.8%) had fatigue, 30
cases (30/54, 55.6%) had significant weight loss, 25 cases
(25/54, 46.3%) had arthralgia, 25 cases (25/54, 46.3%) had
muscle pain, and 11 cases (11/54, 20.4%) had skin rash.
The prevalences of arthragia and skin rash were signif-
icantly lower in patients with MPO-ANCA than those in
patients with PR3-ANCA (46.3% vs. 70.6%, v 2 = 4.49,
P < 0.05; 20.4% vs. 44.1%, v 2 = 5.65, P < 0.05, respec-
tively) (Table 2).
Manifestations of upper respiratory tract
Of the 54 cases with positive MPO-ANCA, 28 cases
(28/54, 51.9%) had upper respiratory tract involvement,
manifested as sinusitis, epistaxis, rhinitis, septal erosions,
perforation, or subglottic stenosis.
Manifestations of lower respiratory tract
Of the 54 cases with positive MPO-ANCA, 42 cases
(42/54, 77.8%) had lung symptoms such as cough, often
with sputum production, and 14 cases (14/54, 25.9%) had
hemoptysis. Twenty-seven cases (27/54, 50.0%) had shad-
ows on one or both lungs and 22 (22/54, 40.7%) cases
had multiple nodules or cavitations. Fifteen cases (15/54,
27.8%) had pulmonary interstitial fibrosis.
No significant differences were found between patients
with MPO-ANCA and PR3-ANCA (Table 2).
Renal manifestations
Of the 54 cases with positive MPO-ANCA, 53 cases
(53/54, 98.1%) had renal involvement, of which 48
cases (48/54, 88.9%) had hematuria, 46 (46/54, 85.2%)
cases had proteinuria, 44 cases (44/54, 81.5%) had el-
evated serum creatinine at the time of diagnosis, and
34 cases (34/54, 63.0%) had acute renal failure. Thirty-
three cases underwent renal biopsy, of which 13 cases
(13/33, 39.4%) had focal segmental fibrinoid necrosis in
glomeruli, 23 cases (23/33, 69.7%) reached the criteria of
crescentic glomerulonephritis (over 50% glomeruli had
large crescents formation), and eight cases (8/33, 24.2%)
had granulomatous leision in renal interstitium.
The prevalence of elevated initial serum creatinine was
significantly higher in patients with MPO-ANCA than
those in patients with PR3-ANCA positive WG (81.5%
vs. 61.8%, v 2 = 4.20, P < 0.05) (Table 2).
Other clinical manifestations
Fifteen cases (15/54, 27.8%) had ophthalmic disease
manifested as conjunctivitis, keratohelcosis, episcleritis
and uveiitis, optical nerve vasculitis, and decline of vision.
Twenty-two cases (22/54, 40.7%) had ear involvements,
manifested as tinnitus, perforation of the tympanic mem-
brane, and decline or loss of hearing. Twenty-three cases
(23/54, 42.6%) had gastrointestinal involvement mani-
fested as nausea, vomiting, anorexia, abdominal pain,
loose bowels, or bloody feces. Twelve cases (12/54, 22.2%)
had neurologic disorders such as peripheral mononeritis
multiplex, dizziness, headache, and coma.
The prevalences of ophthalmic and ear involvement
were significantly lower in MPO-ANCA than those in
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patients with PR3-ANCA (27.8% vs. 58.8%, v 2 = 8.39,
P < 0.01; 40.7% vs. 67.6%, v 2 = 6.04, P < 0.05) (Table 2).
Laboratory findings
Of the 54 cases with positive MPO-ANCA, 42/54 cases
(77.8%) had anemia, 27/54 (50.0%) cases had leuko-
cytosis, 13/54 (24.1%) cases had thrombocytosis, 47/54
(87.0%) had elevated erythrocyte sedimentation rate
(ESR), and 23/54 cases (42.6%) had elevated C-reactive
protein (CRP).
No significant differences could be found between pa-
tients with MPO-ANCA and PR3-ANCA (Table 2).
Disease assessment
The mean score of BVAS was significantly lower in
patients with positive MPO-ANCA than in PR3-ANCA
(22.2 ± 6.21 vs. 24.7 ± 6.87, P < 0.05). There was no
significant difference in the mean system score of VDI
between the two groups of patients (Table 2).
DISCUSSION
Wegener’s granulomatosis, microscopic polyangiitis,
and Churg-Strauss syndrome are small- to medium-vessel
vasculitides linked by overlapping pathology and the
presence of ANCA. They are commonly referred to as the
ANCA-associated systemic vasculitides. The combina-
tion of a cANCA pattern on immunofluorescence testing
and PR3-ANCA is associated with Wegener’s granulo-
matosis [13]. The pANCA pattern, which usually corre-
sponds to the presence of MPO-ANCA in patients with
vasculitis, being more typical of MPA, CSS, and renal-
limited vasculitis, was considered less common in WG in
Caucasian population. In the past eight years, 500 patients
with ANCA-associated systemic vasculitides were diag-
nosed in our single center. Our previous studies showed
that MPO-ANCA was much more common than PR3-
ANCA (about 5:1) in Chinese patients [14, 15]. In the
present study, even in patients with WG, there was a pre-
dominance of MPO-ANCA over PR3-ANCA (54:34), in-
dicating MPO-ANCA–positive WG might not be rare in
Chinese. Whether it is an epidemiologic feature of WG
in Chinese remains to be further studied.
Previous studies suggested MPO-ANCA constituted
only a minority in Caucasion patients with WG, this sub-
group of patients had not been fully investigated except
for a few studies. Schonermarck et al [16] compared seven
patients with MPO-ANCA–positive WG with 21 age- and
gender-matched PR3-ANCA–positive ones. It was found
that patients with MPO-ANCA–positive WG were pre-
dominantly female (5/7, 71.4%), with less organ involve-
ment. Kidneys, eyes, and the peripheral nervous system
also tended to be less involved in MPO-ANCA–positive
WG patients. In the current study, special attention was
directed to the patients with MPO-ANCA–positive WG
with regard to the clinical spectrum of vasculitis manifes-
tions. In patients with MPO-ANCA–positive WG, pre-
dominantly female, the proportion of elevated initial Scr
was significantly higher than that in patients with PR3-
ANCA, which supports the results of Schonermarck’s
study. However, patients in the current study were se-
lected from a single nephrology center; therefore, we
could not exclude a selection bias resulting in more pa-
tients with severe renal involvement.
Ophthalmic and ear involvements were considered to
be more common in WG than in MPA [7]. Interestingly
however, the current study found that the prevalences of
ophthalmic and ear involvement were lower in patients
with MPO-ANCA–positive WG than that in patients
with PR3-ANCA. It was speculated that MPO-ANCA–
positive WG was somewhat more like MPA, whereas
PR3-ANCA–positive WG was somewhat more like “clas-
sic” WG. However, there is substantial overlap in many
of the clinical features of the ANCA-associated systemic
vasculitides. In some cases, distinguishing between two
or more of these diseases on the basis of clinical features
alone is not easy. It was speculated that the difference
between MPO-ANCA–positive and PR3-ANCA–
positive WG might be associated with different mecha-
nisms in the pathogenesis of WG. The role of different
ANCA played in WG was still unclear and needed further
investigations.
In patients with ANCA-associated systemic vasculi-
tides, cANCA and pANCA positive sera usually rec-
ognized PR3 and MPO, respectively. However, it was
reported that sera from a minority of patients with
cANCA recognized autoantigens other than PR3 (such
as MPO) [17], which was supported by our previous study
[15]. In the current study, sera with cANCA exclusively
recognized PR3, and sera with pANCA exclusively recog-
nized MPO. This was probably due to the smaller sample
size.
CONCLUSION
Patients with MPO-ANCA–positive WG are common
in Chinese. There are some differences in the clinical
manifestions between MPO-ANCA–positive and PR3-
ANCA–positive WG, but the mechanism remains to be
further investigated.
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